Abstract
An open comparative randomized clinico-neuropsychological study of 4 cerebrolysin treatment courses was conducted during 19 months. The differences in long-term effects of different medication dosages (10 and 30 ml) were revealed. The higher cerebrolysin dose was more effictive for cognitive functioning of patients. In patients receiving a dosage of 10 ml, the disease progress was significantly more pronounced. The results obtained indicate that a course of cerebrolysin treatment in higher dosages significantly inhibited neurodegenerative process.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Alzheimer Disease / complications*
-
Alzheimer Disease / diagnosis
-
Alzheimer Disease / drug therapy*
-
Amino Acids / administration & dosage
-
Amino Acids / therapeutic use*
-
Cognition Disorders / diagnosis*
-
Cognition Disorders / etiology*
-
Diagnostic and Statistical Manual of Mental Disorders
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Neuropsychological Tests
-
Nootropic Agents / administration & dosage
-
Nootropic Agents / therapeutic use*
Substances
-
Amino Acids
-
Nootropic Agents
-
cerebrolysin